May 23, 2005 — The European Commission has approved a 50-mg/mL formulation of etanercept injection for the treatment of rheumatoid arthritis, and the U.K.'s Medicine and Healthcare Products Regulatory ...
THOUSAND OAKS, Calif., and COLLEGEVILLE, Pa., JUNE 19, 2003 – Amgen (NASDAQ: AMGN), the world's largest biotechnology company, and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today ...
Once weekly ENBREL significantly reduced rheumatoid arthritis pain, inflammation & improved function
THOUSAND OAKS, Calif., and COLLEGEVILLE, Pa., June 19, 2003 - Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced that patients receiving ENBREL(R) ...
Doctors prescribe Enbrel for arthritis, psoriasis, and other conditions. The medication can cause side effects that are mild and some serious ones. Serious side effects of Enbrel include neurologic ...
Pfizer Japan and Takeda Pharmaceutical Company Limited, announced the termination of co-promotion for the rheumatoid arthritis/juvenile idiopathic arthritis treatment "Enbrel" (etanercept (rDNA)), at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results